Clinical Trial Update: SUBLOCADE Long-term Outcomes

View source ↗

Summary

This update reports long-term outcomes for SUBLOCADE in opioid use disorder. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder | Status: COMPLETED